Mangesh Tiwaskar

1.4k total citations
96 papers, 691 citations indexed

About

Mangesh Tiwaskar is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Mangesh Tiwaskar has authored 96 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Cardiology and Cardiovascular Medicine and 15 papers in Physiology. Recurrent topics in Mangesh Tiwaskar's work include Diabetes Treatment and Management (19 papers), Diabetes Management and Research (18 papers) and Blood Pressure and Hypertension Studies (10 papers). Mangesh Tiwaskar is often cited by papers focused on Diabetes Treatment and Management (19 papers), Diabetes Management and Research (18 papers) and Blood Pressure and Hypertension Studies (10 papers). Mangesh Tiwaskar collaborates with scholars based in India, United States and Australia. Mangesh Tiwaskar's co-authors include Shashank Joshi, Agam Vora, Deepak Talwar, Hanmant Barkate, Abdul Samad Ansari, Saiprasad Patil, Sanjay Kalra, Banshi Saboo, Rakesh Sahay and Manash Baruah and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Infectious Diseases and Diabetes & Metabolic Syndrome Clinical Research & Reviews.

In The Last Decade

Mangesh Tiwaskar

75 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mangesh Tiwaskar India 11 254 140 108 90 77 96 691
Salvatore Crisafulli Italy 15 183 0.7× 118 0.8× 100 0.9× 71 0.8× 81 1.1× 38 872
Hanmant Barkate India 11 389 1.5× 55 0.4× 135 1.3× 132 1.5× 120 1.6× 75 832
Mohammad Fathalipour Iran 15 195 0.8× 40 0.3× 115 1.1× 68 0.8× 72 0.9× 43 648
Qing Hu China 16 191 0.8× 54 0.4× 164 1.5× 50 0.6× 56 0.7× 31 722
Jalil Rashedi Iran 13 177 0.7× 80 0.6× 91 0.8× 97 1.1× 28 0.4× 54 507
Manoli Vourvahis United States 21 502 2.0× 60 0.4× 200 1.9× 224 2.5× 32 0.4× 55 1.4k
Altamash Shaikh India 7 280 1.1× 117 0.8× 57 0.5× 31 0.3× 79 1.0× 18 550
Raul M. Alfaro United States 18 274 1.1× 65 0.5× 128 1.2× 187 2.1× 21 0.3× 25 981
Shubham Atal India 10 124 0.5× 61 0.4× 60 0.6× 48 0.5× 54 0.7× 54 462
Henriëtte M. E. Quarles van Ufford Netherlands 15 347 1.4× 40 0.3× 157 1.5× 113 1.3× 171 2.2× 23 1.6k

Countries citing papers authored by Mangesh Tiwaskar

Since Specialization
Citations

This map shows the geographic impact of Mangesh Tiwaskar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mangesh Tiwaskar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mangesh Tiwaskar more than expected).

Fields of papers citing papers by Mangesh Tiwaskar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mangesh Tiwaskar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mangesh Tiwaskar. The network helps show where Mangesh Tiwaskar may publish in the future.

Co-authorship network of co-authors of Mangesh Tiwaskar

This figure shows the co-authorship network connecting the top 25 collaborators of Mangesh Tiwaskar. A scholar is included among the top collaborators of Mangesh Tiwaskar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mangesh Tiwaskar. Mangesh Tiwaskar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalra, Sanjay, Irfan Ahmed Shaikh, Nitin Kapoor, et al.. (2025). An Indian Consensus on Sarcopenia: Epidemiology, Etiology, Clinical Impact, Screening, and Therapeutic Approaches. International Journal of General Medicine. Volume 18. 1731–1745.
2.
Chawla, Manoj, Sunil Jain, AG Unnikrishnan, et al.. (2025). Research Society for the Study of Diabetes in India (RSSDI) multidisciplinary expert consensus recommendations on role of oral fluid, electrolytes, and energy management in persons with diabetes. International Journal of Diabetes in Developing Countries. 45(4). 803–814.
3.
Hannah, Wesley, Ranjit Mohan Anjana, Mangesh Tiwaskar, et al.. (2025). Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility. Journal of the Association of Physicians of India. 73(2). 56–67.
4.
Kesavadev, Jothydev, Banshi Saboo, Manoj Chawla, et al.. (2025). Using digital tools to improve diabetes care in India with continuous glucose monitoring. Therapeutic Advances in Endocrinology and Metabolism. 16. 2465741570–2465741570.
5.
Sharma, Kamal, Tiny Nair, Manoj Chawla, et al.. (2024). INNOVATOR VS. GENERIC: THE REAL MCCOY VS. THE PRETENDER?.
6.
Zargar, Abdul Hamid, et al.. (2023). Commentary on cardiovascular safety of DPP4Is: Focus on Alogliptin. Indian Journal of Pharmacy and Pharmacology. 10(1). 50–53.
7.
8.
Kalra, Sanjay, Jubbin Jacob, AG Unnikrishnan, et al.. (2023). Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India. International Journal of Endocrinology. 2023. 1–10. 1 indexed citations
9.
Bhandari, Sudhir, et al.. (2023). Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19. Journal of the Association of Physicians of India. 71(2). 49–54. 4 indexed citations
10.
Arora, V.K., S K Katiyar, Deepak Talwar, et al.. (2023). Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement. Indian Journal of Tuberculosis. 70(4). 383–389. 2 indexed citations
11.
Joshi, Shashank, et al.. (2022). Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes Mellitus. Journal of the Association of Physicians of India. 70(7). 76–78.
12.
Kapoor, Nitin, Rakesh Sahay, Sanjay Kalra, et al.. (2021). Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective. Diabetes Metabolic Syndrome and Obesity. Volume 14. 1703–1728. 23 indexed citations
13.
Saboo, Banshi, Sujoy Ghosh, Mangesh Tiwaskar, & Rajeev Chawla. (2021). QTc prolongation Safety and Effectiveness of Teneligliptin in Indian patients with type 2 Diabetes Mellitus: A real world study (QSET 2). Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(5). 102264–102264. 3 indexed citations
14.
15.
Joshi, Shashank, Mangesh Tiwaskar, & Siddharth Shah. (2020). COVID 19: Diabetes and Obesity API-ICP Recommendations.. Journal of the Association of Physicians of India. 68(5). 42–44. 5 indexed citations
16.
Das, Ashok Kumar, Sanjay Kalra, Mangesh Tiwaskar, et al.. (2019). Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).. PubMed. 67(12). 65–74. 15 indexed citations
17.
Tiwaskar, Mangesh. (2019). Cefixime-ofloxacin Combination in the Management of Uncomplicated Typhoid Fever in the Indian Community Setting.. PubMed. 67(3). 75–80. 2 indexed citations
18.
Dhamija, Puneet, Sanjay Kalra, Pramod Kumar Sharma, et al.. (2017). Indian College of Physicians (ICP) Position Statement on Pharmacovigilance.. PubMed. 65(3). 63–66. 4 indexed citations
19.
Srinivasa, Ravi N., et al.. (2016). Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.. PubMed. 64(2). 88–93. 17 indexed citations
20.
Upadhyay, Rajesh Kumar, A Muruganathan, Mangesh Tiwaskar, et al.. (2015). API Recommendations for the Management of Typhoid Fever.. PubMed. 63(11). 77–96. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Crisafulli Breakdown of academic impact, for papers by Hanmant Barkate Breakdown of academic impact, for papers by Mohammad Fathalipour Breakdown of academic impact, for papers by Qing Hu Breakdown of academic impact, for papers by Jalil Rashedi Breakdown of academic impact, for papers by Manoli Vourvahis Breakdown of academic impact, for papers by Altamash Shaikh Breakdown of academic impact, for papers by Raul M. Alfaro Breakdown of academic impact, for papers by Shubham Atal Breakdown of academic impact, for papers by Henriëtte M. E. Quarles van Ufford
Rankless by CCL
2026